Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The innovation is particularly suited for bone and cartilage repair
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Move amid evidence of widespread reporting gaps
A major push to sharpen the future of cancer treatment is underway
The company says the platform offers improved manufacturability and functional advantages
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
